Moreover, the 5-point threshold offers a practical advantage in clinical trials, since it represents a significant enough change to be detectable within a reasonable timeframe, allowing for efficient study design and data analysis
However, effectiveness varies from person to person
If you ever notice unusual weakness, persistent fatigue, or a plateau that feels off, bring it up right away
Phase 2 data published in the New England Journal of Medicine (2023) demonstrated substantial weight reduction in participants with obesity, with some individuals achieving weight loss exceeding 20% of body weight over 48 weeks
Weeks 9 through 12: 4mg weekly for those heading to 8mg or 12mg
Commonly prescribed SGLT-2 inhibitors include dapagliflozin, empagliflozin, and canagliflozin